Biomedical Bulletin Newsletters

  1. September 2024
  2. July 2024
  3. February 2024
  4. November 2023
  5. July 2023
  6. April 2023

Press Releases

  1. October 7, 2024 – (IPM 054) – 3-Month Dapivirine Vaginal Ring for HIV Prevention Demonstrates Superior Drug Release Compared to 1-Month Ring
  2. September 11, 2024 – (Contraline) – Contraline & Population Council Announce Option-to-License Agreement for a Revolutionary Male Contraceptive
  3. September 10, 2024 – (Médunik Canada) – Médunik Canada and the Population Council join in a research partnership for a potential new treatment for multiple sclerosis
  4. August 26, 2024 – (FLAS) – Eswatini to roll out first women-controlled HIV prevention product
  5. July 21, 2024 – (CIFF & Global Fund) – CIFF To Propel PrEP Revolution with up to US$2 Million for Immediate Access to PrEP Rings
  6. February 20, 2024 – (Exeltis) – The Population Council’s Center for Biomedical Research Enters Agreement with Exeltis to Develop a Non-Hormonal Multipurpose Intravaginal Ring
  7. November 30, 2023 – (Burness) – Innovative HIV Prevention Product for Women that Promotes Choice – Dapivirine Vaginal Ring (DVR) – Gains Momentum Across Africa
  8. November 14, 2023 – (Grand Challenges Canada) – Population Council Awarded Grand Challenges Canada Grant to Support the Market Introduction of the Dapivirine Vaginal Ring
  9. September 12, 2023 – (Celanese Agreement) – Celanese Announces Agreement with the Population Council for Sustained Release Dual-API Therapeutic
  10. September 8, 2023 – (SwiftPharma Agreement) – SwiftPharma and the Population Council Pursue Agreement to Manufacture Griffithsin Needed for the Development of a Fast-Dissolving Insert for Protection Against HIV
  11. March 13, 2023 – (German PDP) – German Federal Ministry of Education and Research (BMBF) Grant through KfW Development Bank awards Population Council €10 million
  12. October 19, 2022 – (IPM Acquisition) – Population Council and Imres BV Announce Partnership Agreement for Global Distribution of the Monthly Dapivirine Vaginal Ring
  13. October 4, 2022 – (IPM Acquisition) – Population Council Completes Asset Purchase Agreement from the International Partnership for Microbicides, Acquiring the Monthly Dapivirine Ring and Other HIV Prevention Technologies
  14. July 21, 2022 – (IPM Acquisition) – Population Council Acquires the Monthly Dapivirine Ring and Other Woman-centered HIV Prevention Technologies from the International Partnership for Microbicides
  15. January 27, 2022 – (P50) – NIH Center Grant to Develop First Non-Hormonal Vaginal Ring for Pregnancy and STI Prevention
  16. January 27, 2022 – (M360) – Medicines360 and the Population Council Pursue Agreement to Develop Product to Prevent HIV and Unintended Pregnancy for Worldwide Distribution

Center for Biomedical Research (CBR)